OUR MISSION
PHASE ONE is a Los Angeles-based nonprofit dedicated to supporting ground-breaking Phase I and Phase II clinical cancer research, innovative education and treatment programs, and funding forward-thinking leaders in the scientific and medical community.
Every cancer treatment starts with a Phase I clinical trial.
More trials lead to:
MORE HOPE at diagnosis.
MORE OPTIONS for treatment.
MORE LIFE.
WHAT IS A PHASE I CLINICAL TRIAL?
A phase I clinical trial tests the safety, side effects, best dose, and timing of a new treatment. It is the first step in testing a new treatment in humans and phase I clinical trials usually include only a small number of patients. Phase I trials are also required when testing a new combination of previously approved drugs.
PHASE ONE Grantee Dr. Jason Sicklick and his research team at UC San Diego
WHY WE DO WHAT WE DO
This year, 17 million people worldwide will hear the words "You have cancer.”
Phase I clinical trials are an indispensable step in moving new, safer cancer treatments from the lab into everyday patient care. PHASE ONE invests in the very best ideas and innovative research at the earliest stages, in all types of cancer, including rare types that are seriously underfunded.
Founder, Alberto Valner, speaks about his personal experience with cancer.
Board Member, Mieke Neumann, shares why she believes in clinical trials.
Founding member, Mark Freeman, is passionate about giving back.
OUR IMPACT
PHASE ONE has provided 50+ grants for research in 24 different types of cancer– including types that are rare and underfunded.
PHASE ONE’s investment of $23 million has resulted in over $90 million in additional major funding for our grant recipients.
PHASE ONE has assisted with bringing 5 life-saving drugs to market and more approved treatments on the horizon.